Scholars Central

Research articlePublished 27 Feb 2023

Inhibition of Glutamine Transporter SLC1A5 Reverses Resistance to Erlotinib in Human Non-small Cell Lung Cancer

Authors: Zhuo Lu, Tao Wang, Zhen Chen, Shi-Yin Chen, Zhu-Yun Fu, Cai-Feng Xie, You-Kun Jie

1Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, PR China; 2Institute of Geriatrics, Jiangxi Provincial People's Hospital, the First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, PR China; 3Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, PR China; 4Department of Pathology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, PR China; 5Jiujiang Central Blood Station, Jiujiang, Jiangxi, PR China; 6School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, PR China

Cellular and Molecular Biology

Volume 69 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose: The acquired resistance to erlotinib, an EGFR tyrosine kinase inhibitor (EGFR-TKI), is a great challenge in the targeted therapy of non-small cell lung cancer (NSCLC). Targeting glutamine import could re-sensitize the resistant cancer cells to erlotinib. Our results indicated that the glutamine transporter solute carrier 1 family member 5 (SLC1A5) could be a potential target for the treatment of NSCLC, and the application of GPNA, an SCL1A5 inhibitor, may reverse the acquired resistance to erlotinib. Materials and Methods: The cell proliferation was measured by crystal violet staining assay. The expression levels of proteins were checked by western blot. The flow cytometry was used to analyze the cell cycle. CO-IP was used to detect the ubiquitination of indicated proteins. Results: The expression of SLC1A5 in erlotinib-resistant cell lines (PC9ER, HCC827ER) was significantly higher than those in the erlotinib-sensitive cell lines (PC9, HCC827). The proliferation of erlotinib-resistant cells was more dependent on glutamine. Inhibition of SLC1A5 significantly suppressed the growth of NSCLC cells, especially for the erlotinib-resistant cells. Moreover, inhibition of SLC1A5 aggravated the inhibitory efficacy of erlotinib on cell proliferation in erlotinib-resistant cells and induced cell cycle arrest in G0/G1 phase. Mechanistically, SLC1A5 inhibition facilitated PDK1 degradation through the ubiquitin-proteasome pathway, and decreased the expression of p-AKT, Cyclin B1 and CDC42. Discussion: Glutamine and its transporters play important roles in the development of various numbers of cancers. In this study, we showed that the proliferation of erlotinib resistance NSCLC cells exhibited greater dependence on glutamine. Our study highlighted the role of SLC1A5 in promoting the proliferation of NSCLC cells, especially in erlotinib-resistant NSCLC cells. The effect of SLC1A5 on cell growth in NSCLC was related with its metabolism regulation function and its impact on PDK1-AKT signaling pathway. Our results indicated that SLC1A5 would be a potential target for the treatment of EGFR-TKIs resistant NSCLC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cellular and Molecular Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCellular and Molecular Biology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Zhuo Lu”
  • BylineArticles whose byline prints “Tao Wang”
  • BylineArticles whose byline prints “Zhen Chen”
  • BylineArticles whose byline prints “Shi-Yin Chen”
  • BylineArticles whose byline prints “Zhu-Yun Fu”
  • BylineArticles whose byline prints “Cai-Feng Xie”
  • BylineArticles whose byline prints “You-Kun Jie”